Wayside Dialysis, Llc is a medicare approved dialysis facility center in El Paso, Texas and it has 24 dialysis stations. It is located in El Paso county at 10697 N. Loop Dr., El Paso, TX, 79927. You can reach out to the office of Wayside Dialysis, Llc at (915) 790-0538. This dialysis clinic is managed and/or owned by Davita. Wayside Dialysis, Llc has the following ownership type - Profit. It was first certified by medicare in April, 2018. The medicare id for this facility is 672842 and it accepts patients under medicare ESRD program.
| Name | Wayside Dialysis, Llc |
|---|---|
| Location | 10697 N. Loop Dr., El Paso, Texas |
| No. of Dialysis Stations | 24 |
| Medicare ID | 672842 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 10697 N. Loop Dr., El Paso, Texas, 79927 | |
| (915) 790-0538 | |
| Not Available |
News Archive
During embryonic development, sensory and motor fibers interact to form nerves in the limbs. The research team led by Dr. Andrea Huber Br-samle of the Institute of Developmental Genetics of Helmholtz Zentrum M-nchen has now elucidated how this interaction functions at the molecular level: The cell surface receptor neuropilin-1 is present in both sensory and motor nerve fibers and controls their interaction in order to correctly regulate growth.
Repligen Corporation announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read).
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that has received a $4 million venture capital investment.
Recommendations to reduce federal health care spending in a socially and fiscally responsible manner today were made in a letter to the Congressional Joint Committee on Deficit Reduction from the American College of Physicians.
Women recovering from hysterectomies require less morphine to combat pain and are able to recover their lung function more quickly when they receive a combination of two non-morphine-like or "non-opioid" drugs as part of their treatment, a new Queen's study shows.
› Verified 2 days ago